NCT03205150 - Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients | Biotech Hunter

Enrollment

107

Participants

Timeline

Start Date

October 4, 2017

Primary Completion Date

November 11, 2019

Study Completion Date

November 14, 2019

Conditions

Obese Patients With Non-alcoholic Steatohepatitis (NASH)

Interventions

DRUG

LIK066

Film coated tablet of LIK066 either 30mg or 150 mg was mostly administered once daily before lunch, except on Day 56 when it was administered before breakfast and in fasted state on Day 84

DRUG

Placebo

LIK066 0 mg film-coated tablet(Placebo matching tablets) was mostly administered once daily before lunch, except on Day 56 when it was administered before breakfast and in fasted state on Day 84.

Trial Locations (15)

10700

Novartis Investigative Site, Bangkok

37920

Novartis Investigative Site, Knoxville

60002

Novartis Investigative Site, Chiayi City

63110

Novartis Investigative Site, St Louis

64239

Novartis Investigative Site, Tel Aviv

70403

Novartis Investigative Site, Tainan City

70808

Novartis Investigative Site, Baton Rouge

78233

Novartis Investigative Site, Live Oak

194358

Novartis Investigative Site, Saint Petersburg

343621

Novartis Investigative Site, Haifa

C1056ABJ

Novartis Investigative Site, CABA

C1120AAC

Novartis Investigative Site, Buenos Aires

H3P 3P1

Novartis Investigative Site, Montreal

Unknown

Novartis Investigative Site, Ramat Gan

2333 CL

Novartis Investigative Site, Leiden